US 12134642
Antibodies binding to α7β1 integrin antibodies and compositions thereof
granted A61KA61K2039/505A61K39/39541
Quick answer
US patent 12134642 (Antibodies binding to α7β1 integrin antibodies and compositions thereof) held by Pliant Therapeutics, Inc. expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pliant Therapeutics, Inc.
- Grant date
- Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K39/39541, A61K45/06, A61P